Suchergebnisse - "Moskovitz, Mor"

PubPharm (40)

1

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Christopoulos, P. | Harel, M. | McGregor, K. | +34

2

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer : a phase 2 umbrella trial

enthalten in: Nature medicine | 2024

von Besse, B. | Pons-Tostivint, E. | Park, K. | +35

3

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

enthalten in: Journal of neuro-oncology | 2024

von Averbuch, I. | Tschernichovsky, R. | Yust-Katz, S. | +11

4

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: Frontiers in immunology | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

5

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: bioRxiv.org | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

6

A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling

enthalten in: bioRxiv.org | 2023

von Christopoulos, P. | Harel, M. | Lahav, C. | +21

7

UNcommon EGFR Mutations : International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Bar, J. | Peled, N. | Schokrpur, S. | +23

8

The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer : An Israeli prospective study

enthalten in: Journal of geriatric oncology | 2022

von Shachar, S. | Bar-Sela, G. | Peer, A. | +7

9

Correction : Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447

enthalten in: Cancers | 2022

von Bar-Sela, G. | Cohen, I. | Campisi-Pinto, S. | +10

ErratumFor: Cancers (Basel). 2020 Aug 28;12(9):. - PMID 32872248

10

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50

enthalten in: Clinical lung cancer | 2022

von Holtzman, L. | Moskovitz, M. | Urban, D. | +10